Healthcare - Biotechnology - NASDAQ - US
$ 12.03
-13.6 %
$ 637 M
Market Cap
-5.78
P/E
Price Target
Average
92.85%
Revenue Forecast
Estimate
100.31%
EBIT
Estimate
22.42%
Net Income
Estimate
17.81%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Stoke Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for STOK of $23.2 , with forecasts ranging from a low of $18 to a high of $35 .
STOK Lowest Price Target
Wall Street Target
18 USD
49.63%
STOK Average Price Target
Wall Street Target
23.2 USD
92.85%
STOK Highest Price Target
Wall Street Target
35 USD
190.94%
REVENUE FORECAST
Revenue Forecast Chart STOK
EBIT FORECAST
EBIT Forecast Chart STOK
NET INCOME FORECAST
Net Income Chart STOK